Medical Center And Dispensaries Based Reporting

Objectives	- To enhance reporting from the ambulatory health system - To monitor communicable diseases by time, place and person - To detect alerts and outbreaks at local level
Sources of data	- Medical centers and dispensaries of the Ministry of Public Healht MOPH - Medical centers and dispensaries of the Ministry of Social Affairs MOSA - Other governemental medical centers and dispensaries - Medical centers and dispensaries of various Non-Governemetal Organizations NGO - Field medical units
Target diseases and syndromes	- Vaccine preventable diseases: acute flaccid paralysis, measles, rubella, pertussis (whooping cough) and mumps - For other communicable diseases: acute diarrhea, bloody/dysenteric diarrhea, cholera, acute jaundice, acute respiratory infection (including flu-like illness), unexplained fever, scabies and leishmania - Others: asthma, accidents/injuries
Guidelines	Medical center and dispensaries based surveillance guideline: Ar, En
Reporting form	Weekly reporting form
Results	- Latest weekly national bulletin

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N03AX14	LEVIPRAM IV	G	Levetiracetam - 1000mg/100ml	1000mg/100ml	Injectable solution	2,911,659 L.L
N03AX14	LEVETIRACETAM ARROW LAB	G	Levetiracetam - 1000mg	1000mg	Tablet, film coated, breakable	2,940,327 L.L
N03AX14	LEVETIRACETAM BIOGARAN	G	Levetiracetam - 1000mg	1000mg	Tablet, coated, scored	3,191,626 L.L
N03AX14	LEVIPRAM 1000	G	Levetiracetam - 1000mg	1000mg	Tablet, film coated	1,663,805 L.L
N03AX14	LEVIPHAR	G	Levetiracetam - 1000mg	1000mg	Tablet, film coated	2,212,861 L.L
N05BA08	LEXOTANIL	B	Bromazepam - 1.5mg	1.5mg	Tablet, scored	299,677 L.L
G01AF12	LOMEXIN "T"	B	Fenticonazole nitrate - 1,000mg	1,000mg	Ovule	827,771 L.L
D01AE15	LAMISIL	B	Terbinafine HCl - 10mg/g	1%	Cream	616,824 L.L
D01AE15	LAMISIL	B	Terbinafine HCl - 10mg/g	1%	Cream	616,824 L.L
D01AE15	LAMIFEN	G	Terbinafine HCl - 1%	1%	Cream	321,178 L.L
D01AE15	LAMISIL	B	Terbinafine HCl - 10mg/ml	1%	Solution	506,629 L.L
N01BB02	LIDOCAINE ARWAN	G	Lidocaine (HCl) - 1%	1%	Injectable solution	1,995,158 L.L
N01BB02	LIDOCAINE ARWAN	G	Lidocaine (HCl) - 1%	1%	Injectable solution	1,995,158 L.L
N01BB02	LIDOCAINE- ORBUCELL	G	Lidocaine HCl - 1%	1%	Injectable solution	1,787,950 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g, Lidocaine (ampoule) -	0.5g	Injectable powder for solution+diluent	511,940 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g	0.5g	Injectable powder for solution+diluent	511,940 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g	0.5g	Injectable powder for solution	3,455,595 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g	0.5g	Injectable powder for solution+diluent	433,869 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g, Lidocaine (ampoule) -	0.5g	Injectable powder for solution+diluent	403,153 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g, Lidocaine (ampoule) -	0.5g	Injectable powder for solution+diluent	403,153 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g	0.5g	Injectable powder for solution	3,455,595 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g	0.5g	Injectable powder for solution+diluent	511,940 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g	0.5g	Injectable powder for solution+diluent	511,940 L.L
N01BB02	LIDOCAINE ARWAN	G	Lidocaine (HCl) - 0.5%	0.5%	Injectable solution	1,995,158 L.L
S01BA14	LOTEMAX	B	Loteprednol etabonate - 0.5%	0.5%	Drops suspension	1,038,790 L.L
C01AA05	LANOXIN	B	Digoxin - 0.25mg	0.25mg	Tablet	215,015 L.L
S01EE03	LUMIGAN	B	Bimatoprost - 0.1mg/ml	0.1mg/ml	Drops solution	740,457 L.L
S01EE03	LUMIGAN	B	Bimatoprost - 0.1mg/ml	0.1mg/ml	Drops solution	740,457 L.L
D07AB02	LOCOID	B	Hydrocortisone butyrate - 1mg/g	0.1%	Cream	215,015 L.L
D07AB02	LOCOID	B	Hydrocortisone butyrate - 1mg/g	0.1%	Cream	215,015 L.L